Comparative Cost-Effectiveness Analysis of Streptomycin and Ethambutol in the Treatment of Tuberculosis in a University Teaching Hospital in Nigeria

Simple item page
dc.contributor.authorGiwa, A
dc.contributor.authorOsagbemi, G.K
dc.contributor.authorOlayinka, B.O
dc.contributor.authorGiwa, H.B.F
dc.date.accessioned2019-10-15T15:28:23Z
dc.date.available2019-10-15T15:28:23Z
dc.date.issued2009
dc.description.abstractHealthcare organizations, governments and individuals have been forced by prevailing circumstances of economic crisis to be increasingly oriented towards cost containment due to escalating nature of health expenditure. Objective: The objective of this study is to determine the comparative cost effectiveness of various antituberculous therapeutic options and to make recommendation for the adoption of costeffectiveness evaluations in National Health Policy formulation and decision-making. Method Retrospective cost effectiveness analysis was carried out for prescribed/dispended antibiotic to outpatients with tuberculosis among other infectious diseases in outpatients case notes between 2005 and 2007 in Ahmadu Bello University Teaching Hospital, Zaria Nigeria. Results The result shows that ethambutol tablet cost N8.40/unit of effectiveness while streptomycin injection cost N81.50/unit of effectiveness in the treatment of tuberculosis. Ethambutol tablet therefore appears to be more cost effective than streptomycin injection. Subjecting the cost and effectiveness to sensitivity analysis did not change this conclusion. Statistical analysis shows that there is a statistically significant difference in the effectiveness (outcome) of ethambutol (95%) and streptomycin injection (76.73%) (X2 =13.75; p<0.5). Therefore there is association between effectiveness and therapeutic option chosen with ethambutol tablet being a more cost effective option. The result of this study is significant because ethambutol is usually traded off for less cost-effective streptomycin in many cases even when there is no contraindication to the use of ethambutol. CONCLUSION Ethambutol tablet is more cost effective than streptomycin injection at their usual therapeutic doses in combination with isoniazed, rifampicin and pyrazinamide in the treatment of tuberculos1 at the intensive phase.en_US
dc.description.sponsorshipSelfen_US
dc.identifier.citation19. Giwa A, Osagbemi GK, Olayinka BO and Giwa HBF (2009): Comparative Cost-Effectiveness Analysis of Streptomycin and Ethambutol in the Treatment of Tuberculosis in a University Teaching Hospital in Nigeria. African Journal of Clinical and Experimental Microbiology. 10(1); 47-55, Published by African Society for Clinical Microbiologyen_US
dc.identifier.issn1595-689X
dc.identifier.urihttp://hdl.handle.net/123456789/2595
dc.language.isoenen_US
dc.publisherAfrican Society for Clinical Microbiologyen_US
dc.subjectPharmacoeconomicsen_US
dc.subjectcost effectiveness analysisen_US
dc.subjectethambutolen_US
dc.subjectstreptomycinen_US
dc.subjecttuberculoses.en_US
dc.titleComparative Cost-Effectiveness Analysis of Streptomycin and Ethambutol in the Treatment of Tuberculosis in a University Teaching Hospital in Nigeriaen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Comparative CEA Strept & Ehamb. in TB.pdf
Size:
237.29 KB
Format:
Adobe Portable Document Format
Description:
Comparative Cost-Effectiveness Analysis of Streptomycin and Ethambutol in the Treatment of Tuberculosis in a University Teaching Hospital in Nigeria
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections